| 1. 曹华伟，张建东，王玮（通讯作者），胥青芝.肾移植受者衰弱患病情况及相关因素分析.中华医学杂志.2024.103-20.1531-1537.北大核心 |
| 2. Jiyue Wu, Feilong Zhang, Xiang Zheng, Dongshan Chen, Zhen Li, Qing Bi, Xuemeng Qiu, Zejia Sun, Wei Wang*.Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes.. SCIENTIFIC REPORTS.2024.14-1.14431.SCI(含SCIE) |
| 3. Zejia Sun, Feilong Zhang, Zihao Gao, Jiyue Wu, Qing Bi, Xiang Zheng, Jiandong Zhang, Peng Cao, Wei Wang*.Liraglutide alleviates ferroptosis in renal ischemia reperfusion injury via inhibiting macrophage extracellular trap formation.. INTERNATIONAL IMMUNOPHARMACOLOGY.2024.142-B.113258.SCI(含SCIE) |
| 4. Yuqing Li, Jiandong Zhang, Xuemeng Qiu, Yifei Zhang, Jiyue Wu, Qing Bi, Zejia Sun, Wei Wang.Diverse regulated cell death patterns and immune traits in kidney allograft with fibrosis: a prediction of renal allograft failure based on machine learning, single-nucleus RNA sequencing and molecular docking..RENAL FAILURE.2024.46-2. 2435487.SCI(含SCIE) |
| 5. Haojun Wang , Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang*.LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. . CELL DEATH & DISEASE.2024.15-2.165.SCI(含SCIE) |
| 6. Haojun Wang Wen Wen, Mingxi Yao, Tongwang Yang, Dongshan Chen*, Wei Wang*.Deciphering the genomic insights into the coexistence of congenital scoliosis and congenital anomalies of the kidney and urinary tract.. FRONTIERS IN GENETICS.2024.15.1399604.SCI(含SCIE) |
| 7. 姚明希，张建东，曹浩原，李雨清，王玮.免疫检查点抑制剂联合应用在肾细胞癌治疗中的研究进展.中华医学杂志.2024.104-46.4267-4273.北大核心 |
| 8. Jiawan Wang, Wei Wang, Jiandong Zhang, Fei Xiao, Zeya Li, Pengfei Xu, Haozhou Wang, Heng Du, Siqi Liu, Huili Li, Xuan Zhang, Siqi Chen, Zeyu Gao, Sheng Wang, Jun Wang, Moshi Song.Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia-reperfusion in mice.. COMMUNICATIONS BIOLOGY.2024.7-1.1054.SCI(含SCIE) |
| 9. Shen Xihao, Wu Jiyue, Zhang Feilong, Bi Qing, Sun Zejia, Wang Wei.Deciphering the impact of senescence in kidney transplant rejection: An integrative machine learning and multi-omics analysis via bulk and single-cell RNA sequencing..PloS one.2024.19-11.e0312272.SCI(含SCIE) |
| 10. Dongshan Chen, Haoyuan Cao, Xiang Zheng, Haojun Wang, Zengchi Han, Wei Wang.Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target..BMC CANCER.2024.24-1.1024.SCI(含SCIE) |
| 11. 吴极岳，孙泽家，毕青，邱雪萌，王玮.基于生物信息学和机器学习算法构建肾移植术后抗体介导排斥反应的诊断预测模型.中华器官移植杂志.2024.45-10.718-727.北大核心 |
| 12. Qing Bi, Ji‐Yue Wu, Xue‐Meng Qiu, Yu‐Qing Li, Yu‐Yao Yan, Ze‐Jia Sun, Wei Wang*.Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed graft function and renal allograft failure: a machine learning-based exploration in the framework of predictive, preventive, and personalized medicine.. EPMA JOURNAL.2023.14-2.307-328.SCI(含SCIE) |
| 13. Qiu X, Bi Q, Wu J, Sun Z, Wang W*.Role of ferroptosis in fibrosis: From mechanism to potential therapy.. CHINESE MEDICAL JOURNAL.2023.137-7.806-817.SCI(含SCIE) |
| 14. Linbin Hua, Jiyue Wu, Jiashu Ge, Xin Li, Bin You, Wei Wang*,Bin Hu*.Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes. . FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY.2023.11. 1060086.SCI(含SCIE) |
| 15. Sun Z, Gao Z, Li X, Zheng X, Wang W*, Qiao P.Perfusate Neutrophil Gelatinase-Associated Lipocalin, Kidney Injury Molecular-1, Liver-Type Fatty Acid Binding Protein, and Interleukin-18 as Potential Biomarkers to Predict Delayed Graft Function and Long-Term Prognosis in Kidney Transplant Recipients: A Single-Center Retrospective Study.. MEDICAL SCIENCE MONITOR.2023.29. e938758.SCI(含SCIE) |
| 16. Zheng X, Zhang W, Zhou H, Cao R, Shou Z, Zhang S, Cheng Y, Chen X, Ding C, Li N, Shi S, Zhou Q, Chen Q, Chen G, Chen Z, Zhou P, Hu X, Xue W, Zhang X, Na N, Wang W*.A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients.. CHINESE MEDICAL JOURNAL.2023.136-5.607-609.SCI(含SCIE) |
| 17. Wang H, Yang T, Wu J, Chen D, Wang W*.Unveiling the Mystery of SUMO-activating enzyme subunit 1: A Groundbreaking Biomarker in the Early Detection and Advancement of Hepatocellular Carcinoma.. TRANSPLANTATION PROCEEDINGS.2023.55-4.945-951.SCI(含SCIE) |
| 18. 王浩钧,孙泽家, 王玮（通讯作者）.移植肾纤维化的诊断和治疗优化方案.器官移植.2023.1-7.1-7.北大核心 |
| 19. Cao H, Zhang J, Sun Z, Wu J, Hao C, Wang W*.Frailty in kidney transplant candidates and recipients: pathogenesis and intervention strategies.. CHINESE MEDICAL JOURNAL.2023.136-9.1026-1036.SCI(含SCIE) |
| 20. Jiyue Wu, Qing Bi, Xiang Zheng, Huawei Cao, Changzhen Hao, Zejia Sun, Wei Wang*.STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma.BMC Cancer.2022.22.1204.SCI(含SCIE) |
| 21. Feilong Zhang, Yuqing Li, Jiyue Wu, Jiandong Zhang, Peng Cao, Zejia Sun, Wei Wang*.The role of extracellular traps in ischemia reperfusion injury.Frontiers in Immunology.2022.13.1022380.SCI(含SCIE) |
| 22. Zejia Sun , Jiyue Wu , Qing Bi and Wei Wang*.Exosomal lncRNA TUG1 derived from??human urine-derived stem cells attenuates renal ischemia/reperfusion injury by??interacting with??SRSF1 to??regulate ASCL4-mediated ferroptosis.Stem Cell Research & Therapy.2022.13.297.SCI(含SCIE) |
| 23. Qing Bi, Ze-Jia Sun, Ji-Yue Wu, Wei Wang*.Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment.Front Oncol.2022.12.868639.SCI(含SCIE) |
| 24. Zejia Sun, Zihao Gao, Jiyue Wu, Xiang Zheng, Shizhao Jing, Wei Wang*.MSC-Derived Extracellular Vesicles Activate Mitophagy to Alleviate Renal Ischemia/Reperfusion Injury via the miR-223-3p/NLRP3 Axis.Stem Cells Int.2022.2022.6852661.SCI(含SCIE) |
| 25. Jiyue Wu, Zejia Sun, Qing Bi, Wei Wang*.A ferroptosis-related genes model allows for prognosis and treatment stratification of clear cell renal cell carcinoma: a bioinformatics analysis and experimental verification.Front Oncol.2022.12.815223.SCI(含SCIE) |
| 26. Qianchuan Tian , Zhaoqi Zhang , Liang Tan , Fan Yang , Yanan Xu , Yinan Guo , Dong Wei , Changhong Wu , Peng Cao , Jiawei Ji , Wei Wang* , Xubiao Xie , Yong Zhao.Skin and heart allograft rejection solely by long-lived alloreactive TRM cells in skin of severe combined immunodeficient mice.Sci Adv.2022.8(4).eabk0270.SCI(含SCIE) |
| 27. Dongshan Chen, Chen Zhang, Yuanwei Zang, Wei Wang* , Jiandong Zhang.Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma.Front. Genet.2022.13.970900.SCI(含SCIE) |
| 28. Qing Bi, Ji-Yue Wu, Xue-Meng Qiu, Jian-Dong Zhang, Ze-Jia Sun, Wei Wang*.Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis.J Immunol Res.2022.2022.3128933.SCI(含SCIE) |
| 29. Peng Cao, Zejia Sun, Feilong Zhang, Jiandong Zhang, Xiang Zheng, Baozhong Yu, Yong Zhao, Wei Wang, Wei Wang*.TGF-b Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression.Frontiers in Immunology.2022.13.919674.SCI(含SCIE) |
| 30. Cao H, Sun Z, Wu J, Hao C and Wang W*.Metastatic Clear Cell Renal Cell Carcinoma to Pancreas and Distant Organs 24 Years After Radical Nephrectomy: A Case Report and Literature Review.Front. Surg.2022.9.894272.SCI(含SCIE) |
| 31. Jiyue Wu, Feilong Zhang, Xiang Zheng, Jiandong Zhang, Peng Cao, Zejia Sun, Wei Wang*.Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes.Frontiers in Immunology.2022.13.1047367.SCI(含SCIE) |
| 32. Peng Cao, Ji-Yue Wu, Jian-Dong Zhang, Ze-Jia Sun, Xiang Zheng, Bao-Zhong Yu, Hao-Yuan Cao, Fei-Long Zhang, Zi-Hao Gao, Wei Wang*.A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.BMC Cancer.2022.22(1).691.SCI(含SCIE) |
| 33. Peng Cao, Feilong Zhang, Jiandong Zhang, Xiang Zheng, Zejia Sun, Baozhong Yu, Wei Wang*.CYP3A5 genetic polymorphism in Chinese population with renal transplantation: a meta-analysis review.Transplantation Proceedings.2021.-.-.SCI(含SCIE) |
| 34. Jiawei Ji, Yuan Zhuang, Zhemin Lin, Yihang Jiang, Wei Wang*, Xiaodong Zhang.IFN γ induced MDSCs aggravate kidney ischemic-reperfusion injury by regulating innate immune cells.Nephron.2021.146(1).99-109.SCI(含SCIE) |
| 35. Feilong Zhang, Jiyue Wu, Zejia Sun, Dawei Xie, Xiaoyong Yang, Wei Wang*.Nephrogenic adenoma of the renal pelvis：a rare case report and review of the literature.Medicine (Baltimore).2021.100(34).e27025.SCI(含SCIE) |
| 36. Changzhen Hao, Jiandong Zhang, Feilong Zhang, Jiyue Wu, Huawei Cao, Wei Wang*.Mitochondrial DNA may act as a biomarker to predict donor-kidney quality.Clin Transplant.2021.26.e14469.SCI(含SCIE) |
| 37. Jiandong Zhang, Chen Zhang, Peng Cao, Xiang Zheng, Baozhong Yu, Haoyuan Cao, Zihao Gao, Feilong Zhang, Jiyuan Wu, Huawei Cao, Changzhen Hao, Zejia Sun, Wei Wang*.A zinc finger protein gene signature enables bladder cancer treatment stratification.Aging (Albany NY).2021.13(9).13023-13038.SCI(含SCIE) |
| 38. 郁堡中，孙泽家，王玮*.肾移植术后妊娠及生育相关研究进展.中华器官移植杂志.2021.21(03).183-185.自主认定核心期刊 |
| 39. Baozhong Yu，Xiang Zhang，Zejia Sun，Peng Cao，Jiandong Zhang，Wei Wang*.IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival.Front Genet..2021.12.1-9.SCI(含SCIE) |
| 40. Jiyue Wu#，Feilong Zhang#，Jiandong Zhang#，Zejia Sun，Wei Wang*.Advances of miRNAs in kidney graft injury.Transplant Rev (Orlando)..2021.35(1).1-10.SCI(含SCIE) |
| 41. Baozhong Yu#，Jiandong Zhang#，Zejia Sun，Peng Cao，Xiang Zheng，Zihao Gao，Haoyuan Cao，Feilong Zhang，Wei Wang*.Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis.Medicine (Baltimore).2021.100(1).1-11.SCI(含SCIE) |
| 42. Zhang L, Wang W#.Liu L, Zhang Y, Zhang X. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha protects a fibrotic liver from partial hepatectomy-induced advanced liver injury through regulating cell cycle arrest.Basic Clin Pharmacol Toxicol.2021.-.-.SCI(含SCIE) |
| 43. Feilong Zhang#，Jiandong Zhang#，Peng Cao，Zejia Sun，Wei Wang*.The characteristics of regulatory macrophages and their roles in transplantation.Int Immunopharmacol..2021.91.1-11.SCI(含SCIE) |
| 44. 张飞龙，王玮*.细胞免疫治疗在肾移植中的临床转化与前景.中华医学杂志.2021.101(26).2099-2102.自主认定核心期刊 |
| 45. Baozhong Yu#，Xiang Zhang#，Zejia Sun，Peng Cao，Jiandong Zheng，Zihao Gao，Haoyuan Cao，Feilong Zhang，Wei Wang*.The safety and efficacy of doxazosin in medical expulsion therapy for distal ureteric calculi: A meta-analysis.PLoS One.2021.16(1).1-12.SCI(含SCIE) |
| 46. Xiang Zheng, Wei-Jie Zhang, Hua Zhou, Rong-Hua Cao, Zhang-Fei Shou, Shu-Wei Zhang, Ying Cheng, Xu-Chun Chen, Chen-Guang Ding, Zuo-Fu Tang, Ning Li, Shao-Hua Shi, Qiang Zhou, Qiu-Yuan Chen, Gang Chen, Zheng Chen, Pei-Jun Zhou, Xiao-Peng Hu, Xiao-Dong Zhang, Ning Na, Wei Wang*.Study protocol: a randomized controlled trial to evaluate effificacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients.Chinese Medical Journal.2021.-.-.SCI(含SCIE) |
| 47. 蔡继飞，王玮*，任亮，孙泽家，李馨，郑翔，苏路路，张小东.供者血液新型生物标志物在评估移植肾功能恢复延迟中的应用.中华器官移植杂志.2020.41(02).94-98.自主认定核心期刊 |
| 48. Peng Cao，Zejia Sun，Chang Feng，Jiandong Zhang，Feilong Zhang，Wei Wang*，Yong Zhao.Myeloid-derived suppressor cells in transplantation tolerance induction.Int. Immunopharmacol..2020.83.1-10.SCI(含SCIE) |
| 49. 郑翔，谷丽，郎韧，孙兵，李绪言，王玮*.多囊肾合并多囊肝患者肾移植后肝囊肿反复感染行肝移植一例并文献复习.中华器官移植杂志.2020.41(08).470-473.自主认定核心期刊 |
| 50. Haoyuan Cao#，Jiandong Zhang#，Wei Wang*.DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.Technol Cancer Res Treat..2020.11(11).3207-3215.SCI(含SCIE) |
| 51. Li Y#, Wang W#, Yang F#, Xu Y, Feng C, Zhao Y*.The regulatory roles of neutrophils in adaptive immunity.Cell Commun Signal.2019.17(1).147.SCI(含SCIE) |
| 52. Fan Yang#，Yang Li#，Weilong Zou#，Yanan Xu，Hao Wang，Wei Wang*，Yong Zhao*.Adoptive transfer of IFN-γ-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway.Inflammation Research.2019.68(7).545-555.SCI(含SCIE) |
| 53. Ze-Jia Sun, Xiao-Peng Hu, Bo-Han Fan, Wei Wang*.Epstein-Barr virus-positive post-transplant lymphoproliferative disordepresenting as hematochezia and enterobrosis in renal transplant recipients in China: A report of two cases..World J Clin Cases.2019.7(24).4334-4341.SCI(含SCIE) |
| 54. 郁堡中，孙泽家，蒋一航，王玮*.肾移植术后糖尿病的危险因素及研究进展.实用器官移植电子杂志.2019.7（3）.226-230.自主认定核心期刊 |
| 55. 张飞龙, 孙泽家, 曹鹏, 王玮*.调节性巨噬细胞在移植免疫中的研究进展.中华医学杂志.2019.99（34）.2713-2716.自主认定核心期刊 |
| 56. 孙泽家，张小东 ，张希诺， 曹鹏， 李馨， 郑翔 ，郁堡中 ，王玮*.肾移植术后新发供者特异性抗体对受者预后影响的回顾性研究.中华器官移植杂志.2019.40（8）.457-461.自主认定核心期刊 |
| 57. Sun Z, Li X, Zheng X, Cao P, Yu B, Wang W*.Stromal cell-derived factor-1/CXC chemokine receptor 4 axis in injury repair and renal transplantation.J Int Med Res..2019.10(3).5426–5440.SCI(含SCIE) |
| 58. J.-F. Cai, W. Wang*, W. Hao, Z.-J. Sun, L.-L. Su, X. Li, X. Zheng, and X.-D. Zhang..Meta-analysis of Early Versus Late Ureteric Stent Removal After Kidney Transplantation..Transplantation Proceedings.2018.50（10）.3411-3415.SCI(含SCIE) |
| 59. 孙泽家，张小东，任亮，杨晓勇，蔡继飞，李馨，郑翔，王玮*.肌酐下降率预测心脏死亡供体肾移植术后移植肾功能延迟恢复.中华医学杂志.2018.98（1）.36-41.北大核心 |
| 60. 杜鑫，孙泽家，蔡继飞，李馨，刘航，任亮，张小东，王玮*.高致敏二次肾移植患者术前应用硼替佐米行脱敏治疗1例报告及文献复习。.器官移植.2017.8（5）.365-370.自主认定核心期刊 |
| 61. Hui Chen#,Lianjun Zhang#,Peng Wang#,Huiting Su#,Wei Wang,Zhulang Chu,Lianfeng Zhang,Xiaodong Zhang*,Yong Zhao*.mTORC2 controls Th9 polarization and allergic airway inflammation.Allergy.2017.3.8.1-11.SCI(含SCIE) |
| 62. Du X ，Wang W* ，Sun ZJ，Su LL，Zhang XD.meta-analysis on the safety and efficacy of a single high dose of ATG Fresenius in Kidney Transplantation.Transplantation Proceedings.2016.48（6）.2017-2022.SCI(含SCIE) |
| 63. Sun ZJ ，Du X，Su LL，Zhang XD，Wang Y，Ren L，Wang W*.Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in China.Chinese Medical Journal.2016.129（11）.1379-1381.SCI(含SCIE) |
| 64. Sun ZJ, Du X, Su LL, Zhang XD, Wang W*.Efficacy and Safety of Basiliximab Versus Daclizumab in Kidney Transplantation: A Meta-Analysis..Transplantation Proceedings.2015.47(8).2439-2445.SCI(含SCIE) |
| 65. Li H, Feng SJ, Su LL, Wang W*, Zhang XD, Wang SX..Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy.Chinese Medical Journal.2015.128（11）.1351-1357.SCI(含SCIE) |
| 66. Wang W, Feng SJ, Li H, Zhang XD, Wang SX..Correlation of Lower Concentrations of Hydrogen Sulfide with Activation of Protein Kinase CβII in Uremic Accelerated Atherosclerosis Patients.Chinese Medical Journal.2015.128（10）.1465-1470.SCI(含SCIE) |
| 67. 蒋一航，王玮*，胡小鹏，王伟，尹航，刘航，任亮，杨晓勇，范博涵，张小东.稳定期肾移植受者吗替麦考酚酯暴露量研究的药代学和药效学试验.中华器官移植杂志.2015.36（4）.217-224.自主认定核心期刊 |
| 68. 蒋一航，王玮#，胡小鹏，尹航，刘航，任亮，王伟，胡小鹏，范博涵，张小东*.NGAL与Cys c对于肾移植术后早期肾功能恢复的预测作用。2015,2:112-115..中华医学杂志.2015.95（2）.112-115.自主认定核心期刊 |
| 69. Li Han,Li Xiaobei,Feng Sujuan,Zhang Guizhi,Wang Wei* and Wang Shixiang.Sleep disorders and its related risk factors in patients undergoing chronic peritoneal dialysis.Chinese Medical Journal.2014.127(7).1289-1293.SCI(含SCIE) |
| 70. 张希诺，李寒，王玮*，张征，尹航，邱葵，刘航，王伟，胡小鹏，张小东.肾移植受者口服马替麦考酚酯和麦考酚钠肠溶片的临床研究.中华器官移植杂志.2014.35（8）.464-468.自主认定核心期刊 |
| 71. Liang X, WANG Wei*, Li H..Water and sodium restriction on cardiovascular disease in young chronic hemodialysis patients..Chinese Medical Journal.2013.126(9).1667-1672.SCI(含SCIE) |
| 72. WANG Wei, Zhang XN, Yin H, Li XB, Hu XP, Liu H, Wang Y, Zhang XD*..Effects of Bailing capsules for renal transplant recipients: a retrospective clinical study..Chinese Medical Journal.2013.126(10).1895-1899.SCI(含SCIE) |
| 73. WANG Wei, TIAN Hui, YIN Hang, LIU Hang，ZHANG Xiaodong*.Attitudes toward organ donation in China.Chinese Medical Journal.2012.125（1）.56-62.SCI(含SCIE) |
| 74. WANG Wei, YIN Hang, LI Xiaobei, HU Xiaopeng, YANG Xiaoyong, LIU Hang, REN Liang, WANG Yong，ZHANG Xiaodong*.A Retrospective Comparison of the Efficacy and Safety in Kidney Transplant Recipients with Basiliximab and anti-thymocyte globulin.Chinese Medical Journal.2012.125（6）.1135-1140.SCI(含SCIE) |
| 75. 王玮, 尹航, 胡小鹏, 李晓北, 杨晓勇, 任亮, 王勇, 张小东*.生理盐水替代HTK保存液保存活体供肾的临床研究.器官移植杂志.2011.2（5）.269-272.自主认定核心期刊 |
| 76. 田惠忠, 王玮*, 刘航, 张小东.肾移植术后并发肺结核的早期诊治与预防.中华健康管理学杂志.2011.5（6）.345-349.自主认定核心期刊 |
| 77. 王玮, 尹航, 李晓北, 杨晓勇, 任亮, 刘航, 张鹏, 胡小鹏, 王勇, 张小东*..肾移植术后并发双侧字体肾盂和输尿管移行细胞癌16例.中华器官移植杂志.2011.32（8）.474-476.自主认定核心期刊 |
| 78. WANG Wei*, LI Xiaobei, YANG Xiaoyong, and ZHANG Xiaodong.Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection.Chinese Medical Journal.2011.124（12）.1175-1178.SCI(含SCIE) |
| 79. WANG Wei, LI Xiao-Bei, YIN Hang, YANG Xiao-yong, LIU Hang, REN Liang, HU Xiao-peng,WANG Yong and ZHANG Xiao-dong*.Factors affecting the long-term renal allograft survival.Chinese Medical Journal.2011.124（8）.1181-1184.SCI(含SCIE) |
| 80. LI Shi-hai, WANG Wei, HU Xiao-peng, YIN Hang, REN Liang, YANG Xiao-yong, LIU Hang and ZHANG Xiao-dong*.Monitoring immune function after rapid corticosteroid reduction in kidney transplant recipients..Chinese Medical Journal.2011.124（5）.679-682.SCI(含SCIE) |
| 81. YAO Qing-chun, WANG wei, LI Xiao-bei, YIN Hang and ZAHNG Xiao-dong*.Expression characteristics of major histocompatibility complex class I-related chain A antibodies and immunoadsorption effect in sensitized recipients of kidney transplantation..Chinese Medical Journal.2011.124（5）.669-673.SCI(含SCIE) |
| 82. Shihai Li, Wei Wang, Xiaopeng Hu, Liang Ren, Hang Yin, Xiaoyong Yang, Hang Liu, Xiaodong Zhang *.The effects of early rapid corticosteroid reduction on cell-mediated immunity in kidney transplant recipients.Transplant Immunology.2011.24（2）.127-130.SCI(含SCIE) |
| 83. 王玮 刘航 尹航 李晓北 杨晓勇 任亮 胡小鹏 王勇 张小东*.免疫吸附在高致敏肾移植受者中的应用.中华医学杂志.2010.90（36）.2532-2535.自主认定核心期刊 |
| 84. 王玮*，李晓北，尹航，刘航，任亮，杨晓勇，胡小鹏，王勇，张小东.肾移植术后合并卡氏肺囊虫肺炎的早期诊断与治疗.中华器官移植杂志.2010.31（4）.227-230.自主认定核心期刊 |
| 85. 王玮*,李晓北,丁毅,尹航，刘航，胡小鹏，王勇，张小东.肾移植术后侵袭性肺曲霉菌病16例诊治分析.中华医学杂志.2010.90（2）.110-112.自主认定核心期刊 |
| 86. 王玮*,张小东,李晓北,胡小鹏，尹航，刘航，任亮，王勇.移植肾动脉狭窄的诊治20例报告.中华器官移植杂志.2009.30（11）.692-693.自主认定核心期刊 |
| 87. 王玮*，张小东.多药耐药基因多态性与肾移植术后免疫抑制剂应用（下）.国际移植与血液净化杂志.2008.6（6）.19-22.自主认定核心期刊 |
| 88. 王玮*，张小东.多药耐药基因多态性与肾移植术后免疫抑制剂应用（上）.国际移植与血液净化杂志.2008.6（6）.14-18.自主认定核心期刊 |
| 89. 王玮*,张小东,马麟麟，王勇，胡小鹏，陈晓，杨勇.多囊肾患者肾移植术后的临床效果.临床泌尿外科杂志.2006.21(5).331-336.自主认定核心期刊 |
| 90. 王玮*,张小东,丁洁，马麟麟，胡小鹏，王勇，陈晓，管德林.肾移植患者的多药耐药基因外显子26基因型与术后他克莫司的关系.中华器官移植杂志.2006.27(12).728-730.自主认定核心期刊 |
| 91. 王玮*,管德林，张小东,马麟麟，陈晓，胡小鹏，赵勇.多药耐药基因多态性与免疫抑制剂应用关系的研究.中华泌尿外科杂志.2006.27（Suppl）.89-91.自主认定核心期刊 |
| 92. 王玮*,张小东,马麟麟，吕月平，胡小朋，张鹏，王勇，管德林.肾移植中他克莫司的血药浓度与多药耐药基因多态性的关系.中华医学杂志.2005.85（46）.3277-3281.自主认定核心期刊 |
| 93. WANG Wei*,ZHANG Xiao-dong,GUAN De-lin, LV Yue-pin,MA Lin-lin,HU Xiao-peng,ZHANG Peng,WANG Yong,CHEN Xiao.Relationship between MDR1 polymorphism and blood concentration of cyclosporine A.Chinese Medical Journal.2005.118(24).2097-2100.SCI(含SCIE) |
